| pubmed-article:17345556 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17345556 | lifeskim:mentions | umls-concept:C0008972 | lld:lifeskim |
| pubmed-article:17345556 | lifeskim:mentions | umls-concept:C0598391 | lld:lifeskim |
| pubmed-article:17345556 | lifeskim:mentions | umls-concept:C1739462 | lld:lifeskim |
| pubmed-article:17345556 | pubmed:dateCreated | 2007-3-8 | lld:pubmed |
| pubmed-article:17345556 | pubmed:abstractText | Important advances have been made in enzyme replacement therapy in the treatment of lysosomal diseases over the last two decades. Here we review the initial ERT trial using idursulfase in Hunter syndrome (mucopolysaccharidosis type II) and we also examine relevant aspects of the use of this enzyme. | lld:pubmed |
| pubmed-article:17345556 | pubmed:language | spa | lld:pubmed |
| pubmed-article:17345556 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17345556 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17345556 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17345556 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17345556 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17345556 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17345556 | pubmed:issn | 1576-6578 | lld:pubmed |
| pubmed-article:17345556 | pubmed:author | pubmed-author:Gutiérrez-Sol... | lld:pubmed |
| pubmed-article:17345556 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17345556 | pubmed:day | 19 | lld:pubmed |
| pubmed-article:17345556 | pubmed:volume | 44 Suppl 1 | lld:pubmed |
| pubmed-article:17345556 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17345556 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17345556 | pubmed:pagination | S7-S11 | lld:pubmed |
| pubmed-article:17345556 | pubmed:dateRevised | 2009-5-28 | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:meshHeading | pubmed-meshheading:17345556... | lld:pubmed |
| pubmed-article:17345556 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17345556 | pubmed:articleTitle | [Clinical study of enzyme replacement therapy with idursulfase]. | lld:pubmed |
| pubmed-article:17345556 | pubmed:affiliation | Hospital Infantil Universitario Nino Jesus, 28009 Madrid, Espana. | lld:pubmed |
| pubmed-article:17345556 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17345556 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:17345556 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17345556 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:17345556 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
